Intestinal Absorption Mechanism of Dipeptide Angiotensin Converting Enzyme Inhibitors of the Lysyl-Proline Type: Lisinopril and SQ 29,852
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 78 (12), 995-998
- https://doi.org/10.1002/jps.2600781205
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Passive and Carrier-Mediated Intestinal Absorption Components of CaptoprilJournal of Pharmaceutical Sciences, 1988
- Determination of intrinsic membrane transport parameters from perfused intestine experiments: A boundary layer approach to estimating the aqueous and unbiased membrane permeabilitiesJournal of Theoretical Biology, 1988
- (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACEJournal of Medicinal Chemistry, 1988
- Characterization of the Oral Absorption of β-Lactam Antibiotics. I. Cephalosporins: Determination of Intrinsic Membrane Absorption Parameters in the Rat Intestine In SituPharmaceutical Research, 1988
- Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated CompoundsPharmaceutical Research, 1988
- Human intravenous pharmacokinetics and absolute oral bioavailability of cefatrizineAntimicrobial Agents and Chemotherapy, 1983
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980